Previous studies have shown that TRPML1-mediated lysosomal Ca 2+ release is markedly reduced in cells from NPD patients 30, likely due to the inhibitory effects of sphingomyelin accumulation within lysosomal membranes in ASMD. The gene discussed is MCOLN1; the disease is anterior segment dysgenesis.